Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: a multicenter phase II study.
Boukovinas I, Souglakos J, Hatzidaki D, Kakolyris S, Ziras N, Vamvakas L, Polyzos A, Geroyianni A, Agelidou A, Agelaki S, Kalbakis K, Kotsakis A, Mavroudis D, Georgoulias V.
Boukovinas I, et al. Among authors: vamvakas l.
Lung Cancer. 2009 Jan;63(1):77-82. doi: 10.1016/j.lungcan.2008.04.006. Epub 2008 May 27.
Lung Cancer. 2009.
PMID: 18508158
Clinical Trial.